Immune responses to interphotoreceptor retinoid-binding protein and s-antigen in behçet's patients with uveitis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 6, 2010, Pages 3067-3075

  Takeuchi, Masaru ^a   Usui, Yoshihiko ^a   Okunuki, Yoko ^a   Zhang, Lina ^a   Ma, Juan ^a   Yamakawa, Naoyuki ^a   Hattori, Takaaki ^a   Kezuka, Takeshi ^a   Sakai, Jun ichi ^a   Goto, Hiroshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; S ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; EYE PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; RETINA S ANTIGEN; RETINOL BINDING PROTEIN;

ADAPTIVE IMMUNITY; ADULT; ANIMAL TISSUE; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; INNATE IMMUNITY; MALE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; RETINA; SWINE; TH1 CELL; TH17 CELL; TH2 CELL; UVEITIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED;

ADAPTIVE IMMUNITY; ADULT; ARRESTIN; AUTOANTIGENS; BEHCET SYNDROME; CYTOKINES; EYE PROTEINS; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RETINOL-BINDING PROTEINS; TH1 CELLS; TH2 CELLS; UVEITIS;

EID: 77953278410     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4313     Document Type: Article

References (50)

1. France R, Buchanan RN, Wilson MW, Sheldon MB. Relapsing iritis with recurrent ulcers of the mouth and genitalia (Behçet's syndrome): review: with report of additional case. Medicine (Baltimore). 1951;30:335-355.
2. Chajek T, Fainaru M. Behc ̧et's disease: report of 41 cases and a review of the literature. Medicine (Baltimore). 1975;54:179-196.
3. Wong RC, Ellis CN, Diaz LA. Behçet's disease. Int J Dermatol. 1984;23:25-32.
4. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
5. Mizushima Y. Revised diagnostic criteria for Behçet's disease in 1987 [in Japanese]. Ryumachi. 1988;28:66-70.
6. International Study Group for Behçet's Disease. Disease ISGfBs: criteria for diagnosis of Behc ̧et's disease. Lancet. 1990;335:1078-1080.
7. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behçet's disease. Cell Immunol. 1992;140:410-419.
8. Tanaka T, Yamakawa N, Koike N, Suzuki J, Mizuno F, Usui M. Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm. 1999;7:69-74.
9. Direskeneli H. Behçet's disease: infectious aetiology, new autoan-tigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002.
10. Fujimori K, Oh-i K, Takeuchi M, et al. Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246: 285-290.
11. Mizuki N, Meguro A, Tohnai I, Gul A, Ohno S, Mizuki N. Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Oph-thalmol. 2007;51:431-436.
12. Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38: 426-433.
13. Yamamoto JH, Fujino Y, Lin C, Nieda M, Juji T, Masuda K. S-antigen specific T cell clones from a patient with Behçet's disease. Br J Ophthalmol. 1994;78:927-932.
14. Jobin D, Thillaye B, de Kozak Y, Sainte-Laudy J, Faure JP, le Hoang P. Severe retinochoroidopathy: variations of humoral and cellular immunity to S-antigen in a longitudinal study. Curr Eye Res. 1990; 9(suppl):91-96.
15. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol. 1993;77:584-589.
16. Lee KH, Chung HS, Kim HS, et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum. 2003;48:2025-2035.
17. Mor F, Weinberger A, Cohen IR. Identification of alpha-tropomy-osin as a target self-antigen in Behçet's syndrome. Eur J Immunol. 2002;32:356-365.
18. Mahesh SP, Li Z, Buggage R, et al. Alpha tropomyosin as a self-antigen in patients with Behçet's disease. Clin Exp Immunol. 2005;140:368-375.
19. Okunuki Y, Usui Y, Kezuka T, et al. Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol Vis. 2008;14:1094-1104.
20. Okunuki Y, Usui Y, Takeuchi M, et al. Proteomic surveillance of autoimmunity in Behçet's disease with uveitis: selenium binding protein is a novel autoantigen in Behçet's disease. Exp Eye Res. 2007;84:823-831.
21. Meguro A, Ota M, Katsuyama Y, et al. Association of the toll-like receptor 4 gene polymorphisms with Behçet's disease. Ann Rheum Dis. 2008;67:725-727.
22. Nara K, Kurokawa MS, Chiba S, et al. Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol. 2008;152:245-251.
23. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Beh-çet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417-424.
24. de Smet MD, Dayan M. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthalmol Vis Sci. 2000;41:3480-3484.
25. Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of mono-cyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544-1549.
26. Zhao C, Yang P, He H, et al. S-antigen specific T helper type 1 response is present in Behçet's disease. Mol Vis. 2008;14:1456-1464.
27. Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol. 2006;142:429-434.
28. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42: 1967-1974.
29. Koarada S, Haruta Y, Tada Y, et al. Increased entry of CD4 + T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behçet's disease. Rheumatology (Oxford). 2004;43:843-851.
30. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. JExp Med. 2005;201:233-240.
31. Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49: 3058-3064.
32. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/ STAT1. Nat Med. 2007;13:711-718.
33. Redmond TM, Wiggert B, Robey FA, et al. Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, a unique extracellular matrix component of the retina. Biochemistry. 1985;24:787-793.
34. Dorey C, Cozette J, Faure JP. A simple and rapid method for isolation of retinal S antigen. Ophthalmic Res. 1982;14:249-255
35. Itoh Y, Inoko H, Kulski JK, et al. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behçet's disease by a PCR-SSOP-Luminex method. Tissue Antigens. 2006;67:390-394.
36. Mizuki N, Ohno S, Ando H, et al. A strong association between HLA-B*5101 and Behcet's disease in Greek patients. Tissue Antigens. 1997;50:57-60.
37. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982;100:1455-1458.
38. de Smet MD, Yamamoto JH, Mochizuki M, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990;110:135-142.
39. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol. 2005;23:1-21.
40. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.JExp Med. 2008;205:799-810.
41. Agarwal RK, Horai R, Viley AM, et al. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms. J Immunol. 2008;180:5423-5429
42. Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis. Jpn J Ophthalmol. 2001; 45:463-469.
43. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleu-kin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765.
44. Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev. 2005;204:9-26.
45. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2- and interferon-gamma-pro-ducing T cells in patients with active Behcet's disease. Invest Ophthalmol Vis Sci. 1998;39:996-1004.
46. + T cells after combined low-dose cyclo-sporine/prednisone treatment in patients with Behcet's uveitis. Invest Ophthalmol Vis Sci. 2005;46:2458-2464.
47. Verity DH, Wallace GR, Vaughan RW, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens. 1999;54:264-272.
48. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B. Serum inter-leukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Clin Exp Dermatol. 2005;30:61-63.
49. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993;23:224-231.
50. Whichelow CE, Hitman GA, Raafat I, Bottazzo GF, Sachs JA. The effect of TNF-B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet. 1996;23:425-435